Testosterone Replacement Therapy for Men: What TRT Is, Who Needs It, and What to Expect

Testosterone decline is a normal part of male aging, but it is not inevitable that you must suffer its effects. Clinical hypogonadism — diagnosed low testosterone — affects a significant and growing proportion of men over 40, but even men whose levels fall within the broad "low-normal" reference range can be profoundly symptomatic. The reference range encompasses a wide population, including elderly and sedentary men, and "within range" is not the same as optimal. Testosterone Replacement Therapy restores testosterone to the upper-optimal range of a healthy young adult — not artificially supraphysiologic levels associated with anabolic steroid use — with the goal of eliminating symptoms and protecting long-term metabolic, cardiovascular, and cognitive health.

Symptoms of Low Testosterone in Men

• Persistent fatigue and low energy despite adequate sleep and a reasonable workload
• Reduced muscle mass and difficulty building or maintaining strength despite consistent training
• Increased body fat, particularly visceral fat around the abdomen, that does not respond normally to diet and exercise
• Low libido and diminished sexual performance, including reduced morning erections and slower arousal
• Mood changes including chronic irritability, low motivation, reduced competitiveness, and depressive episodes
• Difficulty concentrating, poor working memory, and a generalized sense of cognitive slowing
• Poor sleep quality — difficulty falling asleep, reduced deep sleep, and feeling unrefreshed in the morning

How TRT Works

TRT replaces the testosterone your testes are no longer producing in adequate amounts. The most common and clinically effective delivery method is weekly intramuscular or subcutaneous self-injection, which produces stable, predictable serum levels and is the most cost-efficient option. Daily topical creams or gels offer a needle-free alternative with slightly more variability in absorption — appropriate for men who strongly prefer to avoid injections. Subcutaneous pellets, implanted every three to five months by a provider, deliver a consistent, maintenance-free hormone supply with no daily or weekly action required. At Opulent, we determine the optimal delivery method based on your lifestyle preferences, clinical response, and monitoring results rather than defaulting to a single approach for all patients.

The Optimization Process at Opulent

We begin with a comprehensive baseline panel that includes total testosterone, free testosterone, LH, FSH, estradiol, SHBG, PSA, complete blood count, and a full metabolic panel. This establishes your starting point, identifies any contraindications, and provides the context needed to interpret your symptoms. After initiating TRT, we schedule a follow-up lab draw at six weeks to assess your hormonal response and fine-tune dosing. Once levels are stable and symptoms are well-controlled, monitoring shifts to every six months. The treatment target is the upper quartile of the physiological normal range — a level associated with optimal symptom resolution and long-term health benefits without driving hematocrit elevation or other adverse effects.

Managing Estrogen on TRT

Testosterone converts to estradiol via the aromatase enzyme, and estradiol elevation on TRT can paradoxically produce symptoms that mimic low testosterone — fluid retention, emotional blunting, reduced libido, and nipple sensitivity. We monitor estradiol at every lab draw and address elevations when they are clinically meaningful. Some patients benefit from low-dose aromatase inhibitor therapy; many do not need it at all and do well with dose or delivery method adjustments. Over-suppression of estradiol is equally problematic — estrogen is important for cardiovascular function, joint health, and bone density in men, and aggressive aromatase inhibition creates its own risks. We manage this balance carefully rather than applying a formulaic protocol.

What About Fertility?

Exogenous testosterone suppresses the pituitary signals — LH and FSH — that drive the testes to produce both natural testosterone and sperm. This means that standard TRT alone reduces sperm production substantially and can lead to infertility. Men who want to preserve the possibility of future biological children must have this conversation before starting TRT. Co-administration of HCG maintains testicular stimulation and sperm production alongside TRT for men who wish to keep that option open. Clomiphene citrate represents an entirely different approach — a non-testosterone medication that stimulates the pituitary to increase LH and FSH, raising endogenous testosterone without introducing exogenous hormone. This is appropriate for younger men or those with fertility as a primary concern.